Plain-English translation of NCT02945579 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether certain breast cancer patients can avoid surgery altogether if their cancer responds exceptionally well to chemotherapy or hormone therapy before treatment. Researchers want to see if radiation therapy alone, or in some cases just careful monitoring with biopsies, can work as safely as surgery for patients whose tumors shrink dramatically. The goal is to help patients keep their breast while still treating their cancer effectively.
Breast cancer surgery can affect how a breast looks and feels, and some women want to avoid it if possible. This trial exists to find out whether patients whose cancers respond very well to pre-surgery chemotherapy or hormone therapy can safely skip the surgery step and rely on radiation or monitoring instead.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will first receive standard chemotherapy or hormone therapy to shrink your tumor. After this treatment, doctors will take a biopsy (a small tissue sample) to see how well your cancer responded. If your cancer has shrunk dramatically, you may skip surgery and instead receive either radiation therapy (15-25 daily treatments over several weeks) or continue hormone therapy with close monitoring. You will then have check-ups and imaging every 6 months for up to 10 years to watch for any sign of cancer returning, and you will answer questionnaires about how you're doing physically and emotionally.
AI-generated summary from trial data · Oct 3, 2026 · Not medical advice
United States